Related Content
Download content relating to this event and topic.
3rd ANZ Biologics Festival 2025
Australia and New Zealand's Preeminent Conference on Biologics
The 3rd ANZ Biologics Festival 2025 unites biopharma leaders to advance Australia & New Zealand's biologics industry through innovation partnerships and manufacturing expansion.
300
+
Attendees
120
+
Companies
50
+
Speakers
20
+
Networking Hours
10
+
Case Studies
About the Event
Excellence in Biologics Manufacturing, Cell and Gene Therapy, and RNA Therapeutics for Australia & New Zealand's Future Biologics Industry.
With a biotechnology sector benchmarked for global excellence due to world-class facilities, researchers, and regulation, the ANZ region has a promising future for biologics innovation and manufacturing. The path ahead will require a focus on further commercial translation of research, and as such, partnerships and collaborations will be critical. Expanding sovereign manufacturing in Australia & New Zealand will also play a massive role in uplifting the sector in the region.
The 3rd ANZ Biologics Festival 2025 is the region's premier conference that aims to gather the innovators, pioneers, and leaders in the biologics fraternity, including Biologics, Biosimilars, Vaccines, Cell and Gene Therapy (CGT), and RNA Therapeutics, to showcase the latest from ideation to commercialization phase and beyond. It provides the right environment to meet the entire biopharma fraternity under one roof.
Join us to bring investment to Australia & New Zealand's bio sector and explore a wealth of opportunities in biologics innovation, expanding the region's manufacturing footprint, and advancing cell and gene therapy and RNA therapeutics. The 2025 festival will feature dedicated tracks on Biologics Manufacturing, Cell and Gene Therapy, and RNA Therapeutics, offering a comprehensive view of the latest advancements and challenges in these critical areas.
.png)
Speakers
Esteemed Voices From the Industry
Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders.
Lukasz Kowalczyk
Senior Scientist
AdAlta
Australia
Shigetomo Tsujihata
General Manager
FUJIFILM Toyama Chemical
Japan
Graham Heery
Associate Director Nonclinical & CMC
Starpharma
Australia
Marija Dramicanin
Head of Protein Production Facility at WEHI
WEHI Protein Production Facility
Australia
Lucas Litewka
Director - Clinical Trials Centre
University of the Sunshine Coast
Australia
Colin Pouton
Pharmaceutical Biology
Monash University
Australia
Edmund Ang
Senior Technical Expert, Field Technology Management Asia Pacific
Merck
Singapore
Oksana Zdanska
Medical Director
ImmVirX
Australia
Tim Hirst
Chairman & CEO
GPN Vaccines
Australia
Xenia Sango
Chief Executive Officer and Managing Director
Vivazome Therapeutics
Australia
Vihandha Wickramasinghe
Head, RNA Biology and Cancer Laboratory
Peter MacCallum Cancer Centre
Australia
Tim Oldham
Chief Executive Officer & Managing Director
Adalta
Australia
Thomas Preiss
Director of Shine-Dalgarno Centre for RNA Innovation, Professor of RNA Biology
The Australian National University
Australia
Tam C. Nguyen
Deputy Director of Research
St. Vincent’s Hospital Melbourne
Australia
Richard Berry
Vice President, Biologics & Drug Discovery
oNKo-innate
Australia
Rebecca Skinner
Director, Research and Industry Development, mRNA Victoria
Government of Victoria
Australia
Rebecca McQualter
Chief Operating Officer
Chimeric Therapeutics
Australia
Paul McDonald
Chief Executive Officer
IDT
Australia
Nicholas Huntington
Co-founder & CSO at oNKo-Innate, Director of Research, Cancer Immunology
Monash University
Australia
Mike Zablocki
General Manager
Malaghan Institute of Medical Research
New Zealand
Michelle McIntosh
Theme Leader, Drug Delivery, Disposition and Dynamics
Monash University
Australia
Michael Baker
Chief Executive Officer & Managing Director,
Arovella Therapeutics
Australia
Marco Herold
Chief Executive Officer, Olivia Newton-John Cancer Research Institute
University of Melbourne, NHMRC Investigator
Australia
Larisa Chisholm
Chief Operating Officer
Denteric
Australia
Joshua Ooi
Head, Regulatory T-cell Therapies
Monash University
Australia
Jolanta Airey
Chief Medical Officer
Cynata Therapeutics
Australia
John Robson
Managing Director
BioOra
New Zealand
John Power
Senior Director
BioNTech SE
Australia
Jerry Kanellos
Chief Scientific Officer
Immuron
Australia
Jennifer Short
Director
Monash Centre for Advanced mRNA Medicines Manufacturing and Workforce Training
Australia
Jane Oliaro
Chief Scientist
Peter MacCallum Cancer Centre
Australia
Jamie Triccas
Deputy Director
University of Sydney
Australia
Ilya Vensky
Co-founder and Chief Executive Officer
Helico Bio
New Zealand
Ian Nisbet
Chief Operating Officer
Cartherics
Australia
Hemasunder Reddy
Director-Asia Pacific
Pfanstiehl
Singapore
Greg Troiano
Chief Manufacturing Officer, mRNA CoE
Sanofi
USA
Gisela Mautner
Chief Executive Officer and Managing Director
Noxopharm
Australia
George Vuckovic
Assistant Secretary, Scientific Evaluation Branch
Therapeutic Goods Administration
Australia
Ebony Fietz
Drug Development Manager
Currus Biologics
Australia
Diego Correa
VP & Global Head
Cell and Gene Therapy Center of Excellence (CAGT-COE), IQVIA
Australia
Deborah Rathjen
Chief Executive Officer
Carina Biotech
Australia
David Winkler
Professor of Biochemistry and Chemistry
La Trobe University
Australia
Craig Newton
Executive Director & Founder
VivaZome Therapeutics
Australia
Chunlin Xin
Vice President
CanSino Biologics Inc.
China
Cheng-Yi Jerry Kuo
Vice General Manager
UWELL BioPharma
Taiwan
Carolyn Tucek-Szabo
Senior Director, Global Regulatory Science Lead – Australia/NZ, Policy & Liaison – Southeast Asia,
Moderna
Australia
Ben Hughes
Director of Strategic Development
Therapeutic Innovation Australia
Australia
Silviu Itescu
Chief Executive Officer
Mesoblast
Australia
Registration
Choose a plan that fits your role, company, and industry.
APAC Biopharma / Academic
SGD 2,095
FINAL CALL
END-USER PRICING IS APPLICABLE TO:
Company Profiles: Biopharma, BIG Pharmas, APAC Academic & Research Institutes in APAC (including ANZ)
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.
For Companies Outside Singapore
Get StartedFor Singapore-Based Companies
Get startedNON-APAC Biopharma / Academic
SGD 2,595
FINAL CALL
END-USER PRICING IS APPLICABLE TO:
Company Profiles: Biopharma, BIG Pharmas, Academic & Research Institutes outisde of APAC
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.
For Companies Outside Singapore
Get StartedFor Singapore-Based Companies
Get startedService or Solution Provider / Big Pharma
SGD 3,595
FINAL CALL
SOLUTION PROVIDER PRICING IS APPLICABLE TO:
Company Profile: Technology and Solutions Provider, Asian/International Biopharma, BIG Pharmas, CMO’s, CRO's, Asian Academic/Research Institutes.
Job Profiles: Business Development, Marketing & Sales
For Companies Outside Singapore
Get StartedFor Singapore-Based Companies
Get startedWant to Speak at This Event?
Join the roster of esteemed colleagues to discuss what you or your company are bringing to the biopharmaceutical industry.
Agenda at a Glance
View the agenda for
3rd ANZ Biologics Festival 2025
ANZ Biologics Festival 2025
- Current And Future State of the ANZ Biologics Market: An overview and forecast of trends, challenges, and opportunities in the biologics market in Australia and New Zealand.
- Upstream Processing – Process Optimization & Intensification: Strategies and advancements in optimizing and intensifying the initial stages of biologics production to enhance efficiency and productivity.
- Downstream Processing – Purification & Recovery for Better Product Efficiency & Yield: Techniques and innovations in purifying and recovering biologics to improve product quality and yield.
- GMP Manufacturing, Analytics & Quality Control: Best practices and technologies for ensuring Good Manufacturing Practices (GMP), precise analytics, and rigorous quality control in biologics production.
- Bioprocessing 4.0: Digitalization, AI, and Machine Learning for Manufacturing Efficiencies: Examining how digitalization, AI, and machine learning technologies are revolutionizing manufacturing processes to enhance efficiency and productivity in bioprocessing.
- Designing & Executing Clinical Trials in the ANZ Region – Lessons Learnt: Sharing insights and experiences from designing and conducting clinical trials in Australia and New Zealand, highlighting key takeaways and best practices.
- Biopharma Case Studies from ANZ Region: Presenting real-world case studies from biopharma companies in the ANZ region, showcasing successful strategies and innovations in biologics development.
- Supply-Chain Management & Temperature Controlled Logistics: Discussing strategies and solutions for effective supply-chain management and maintaining temperature control in the logistics of biologics to ensure product integrity and quality
ANZ Next-Gen Cell & Gene Therapeutics Forum
- Current & Future Prospects for Cell & Gene Therapies in ANZ: Exploring the present landscape and future opportunities for cell and gene therapies in Australia and New Zealand, including regulatory and market trends.
- Translational Strategy for Pre-Clinical and Clinical Programs: Discussing strategies to effectively transition therapies from pre-clinical research to clinical development, ensuring successful translation of scientific discoveries into clinical applications.
- Building a Global Clinical Trial for Cell & Gene Therapies: Highlighting the challenges and best practices for designing and executing international clinical trials for cell and gene therapies, with a focus on regulatory and logistical considerations.
- CGT Manufacturing Innovations for Safe, Efficient, and Scalable Therapies: Presenting cutting-edge manufacturing techniques and innovations that enhance the safety, efficiency, and scalability of cell and gene therapies.
- Case Studies: Promising CGT Therapies from ANZ: Showcasing successful case studies of innovative cell and gene therapies developed in the ANZ region, highlighting clinical outcomes and potential impact.
Next-Gen RNA Therapeutics Forum
- Growing RNA Research & Manufacturing Capability in the ANZ Region: Discussing the expansion and advancements in RNA research and manufacturing capabilities within Australia and New Zealand, focusing on infrastructure and technological developments.
- Accelerating Vaccine Manufacture with mRNA Technology: Exploring how mRNA technology is revolutionizing vaccine development and manufacturing processes, enabling faster and more efficient production.
- Optimizing Delivery Platforms for Next Gen RNA Therapeutics: Examining advanced delivery systems and technologies designed to enhance the efficacy and safety of next-generation RNA-based therapeutics.
- Case Studies: Breakthrough RNA Therapies from ANZ: Showcasing successful RNA therapies developed in the ANZ region, highlighting their innovative approaches and clinical outcomes.
Ready to attend?
Register today to get limited super access and save big.
Platinum
Sartorius
Sartorius Stedim Biotech is a leading partner of the biopharma industry. Our solutions support our customers in producing drugs safely, timely and economically. The key product categories of our company are cell cultivation, fermentation, filtration, purification, and fluid management.
Visit WebsiteGold
No items found.
Silver
Pfanstiehl
Pfanstiehl is the market leader of high purity, low endotoxin, low metal excipients for biologics, biosimilars, vaccines, cell culture media and injectable (liquid and lyophilized) formulations and supplies its products to nearly all leading global biopharmaceutical companies. Pfanstiehl was founded in 1919 and currently celebrating its 103rd anniversary year in 2022. Pfanstiehl is headquartered at Waukegan, IL, USA and has diverse global technical support team across the globe in USA, Europe & APAC.
Visit WebsiteBronze & Associate
Exhibition & Networking
.png)
ALMAC
Almac Clinical Services have been partnering with clients for 30+ years, we set the standard for developing effective supply chain strategies that ensures our sponsors can overcome their unique challenges and deliver supply continuity to patients wherever they are in the world. We have a range of tools and services to help you achieve this, from forecasting/inventory management, supply chain strategy to global logistics management, end-to-end temperature solutions, IRT set-up and strategy, direct to patient distribution and pharmacy services alongside our clinical packaging and labelling facilities. When you partner with Almac you are partnering with experts who Supply With CareTM
Visit Website
ACRO Biosystems
ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation. The company spans across the globe and maintains offices, R&D centers, and production bases in over 10 different cities within the United States, Switzerland, England and Germany. ACROBiosystems Group has established numerous long-term and stable partnerships with the world’s top pharmaceutical enterprises, including Pfizer, Novartis, and Johnson & Johnson, and numerous well-known academic institutes.
Visit Website
QuickStat
For 43 years, QuickSTAT has been providing the leading pharma and biotech companies 24/7/365 global life science logistics solutions from R&D, clinical trials through to commercialization. Our logistics experts provide time-and temperature-sensitive transport of clinical research samples, cell and gene therapies, investigational drugs, clinical trial supplies and vaccines, to bring new drugs to market. Strict chain of custody, chain of identity and GDP protocols ensure product integrity and patient safety for all clinical and commercial personalized medicines QuickSTAT transports. Consultation and procurement of proper packaging—from controlled room temperature to cryofrozen. Next-gen IT logistics software provided for managing your clinical supply chain with real-time temperature and tracking technology.
Visit Website
Programme & Showcase
No items found.
Foundation
Media & Publicity
No items found.
Want to Sponsor This Event?
Contact the IMAPAC to learn about our sponsorship process, rates and more.
.jpg)
Pre Conference Workshops
Visit the workshop page to view more content.
.png)
Frequently Asked Questions
How can I stay updated on event details and announcements?
To stay informed about event updates, including date, venue, and agenda, please subscribe to our newsletter on our event website. You can also follow our official social media channels for real-time updates and announcements.
What can I expect to learn and explore during the event?
The conference will provide a comprehensive learning experience covering various aspects of the dynamic biopharmaceutical industry, ensuring attendees gain valuable insights and knowledge.
What safety measures will be in place to ensure the safety of attendees?
We are committed to ensuring the safety and well-being of all attendees. We will implement rigorous safety measures in line with local health guidelines and regulations. Specific safety measures will be communicated closer to the event date to ensure they align with the most up-to-date health recommendations. Rest assured, your safety is our priority.
Is there a cancellation or refund policy if I can't attend after registering?
Yes, we have a cancellation and refund policy in place. Please refer to our “Cancellation Policy” on our website for details on how to request a refund if you are unable to attend.
Can I submit a presentation to be a speaker at this event?
We welcome presentation submissions. If you’re interested in speaking at the event, please visit this page on our website for submission guidelines and deadlines.
What type of professionals benefit most from attending?
Our event is designed to cater to a wide range of professionals within the biopharmaceutical industry, including researchers, scientists, executives, regulatory experts, and professionals involved in drug development and manufacturing.
What advantages does this conference offer participants?
Participants can expect to gain insights from industry experts, network with peers, and stay up-to-date with the latest trends and innovations in biopharmaceuticals
Are there networking opportunities or special events planned?
Yes, we have networking sessions, workshops, and social events scheduled throughout the event to facilitate connections and collaborations among attendees.
Are there sponsorship opportunities for this event?
Yes, we offer sponsorship and exhibition opportunities for businesses and organizations. Please visit our this page on our website for more information.
How can I register for the event?
To register for the event, you'll find multiple "register" buttons on this page to get started. You’ll find detailed instructions and options for registration, including pricing and deadlines.
Be a Part of This Event!
Don't miss out on unique networking, speaking and sponsorship opportunities.